Alembic Pharma gains 0.92% on USFDA nod for Sacubitril and Valsartan tablets
Alembic Pharmaceuticals Ltd’s shares were up by 0.92 per cent after the company reported that the US Food & Drug Administration granted final approval for its Abbreviated New Drug Application (ANDA) for Sacubitril and Valsartan tablets in various …